The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics
NCT02956278
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Chronic Gout
Hyperuricemia
Interventions
DRUG:
Allopurinol
OTHER:
Placebo
Sponsor
University of California, San Francisco
Collaborators
[object Object]
[object Object]